Ceftriaxone Use Evaluation in Western Zone Tigray Hospitals, Ethiopia: A Retrospective Cross-Sectional Study.

Tewodros SheguteMulugeta HiruyHaftom HadushLeake Gebremeskel

Published in: BioMed research international (2023)

The appropriateness of ceftriaxone use in Kahsay Abera and Mearg hospitals was 247 (61.8%) and 252 (63%), respectively, in which about one-third of patients' charts were not compliant with the standard treatment guidelines of Ethiopia for general hospitals. In Kahsay Abera and Mearg hospitals, the empiric use of ceftriaxone was 262 (65.5%) and 375 (93.8%), respectively.

Keyphrases

healthcare
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
clinical practice
patient reported
replacement therapy